TheraRadar
Clinical-Stage Companies / Haisco Pharmaceutical Group

Haisco Pharmaceutical Group

Pre-Approval PRO BETA
94
Total Trials
20
Phase 3
35
Phase 2
22
Recruiting
814
Score

Pipeline by Phase

Phase 3
20
Phase 2
35
Phase 1
38

Therapeutic Focus

Healthy Chronic Obstructive Pulmonary Disease (COPD) Paroxysmal Nocturnal Hemoglobinuria (PNH) Anesthesia Pain After Surgery

Clinical Trials (94)

NCT07186426 Phase 3 RECRUITING

A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic Surgery

Started: 7/28/2025

NCT07390123 Phase 3 RECRUITING

Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN

Started: 2/1/2026

NCT06660992 Phase 3 RECRUITING

A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis

Started: 9/30/2024

NCT07519070 Phase 3 NOT YET RECRUITING

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis

Started: 4/5/2026

NCT07510945 Phase 3 NOT YET RECRUITING

HSK3486 (Cipepofol) Injectable Emulsion for Induction of General Anesthesia in Pediatric Subjects Undergoing Elective Surgery

Started: 5/1/2026

NCT06643078 Phase 3 COMPLETED

A Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients With COPD

Started: 12/11/2023

NCT07503587 Phase 3 NOT YET RECRUITING

Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary Fibrosis

Started: 4/5/2026

NCT07052838 Phase 3 COMPLETED

Efficacy and Safety of HSK39297 in Anti-C5 Treated PNH Patients With Anemia

Started: 5/12/2025

NCT06799546 Phase 3 COMPLETED

A Phase III Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Are Naive to Complement Inhibitor Therapy

Started: 2/13/2025

NCT05890053 Phase 3 COMPLETED

To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral Neuralgia

Started: 2/17/2022

NCT06391931 Phase 3 COMPLETED

A Multicenter, Open, Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of Cipepofol Injection for General Anesthesia in Pediatric Patients Undergoing Elective Surgery

Started: 4/7/2024

NCT05135390 Phase 3 COMPLETED

A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients with Chronic Kidney Disease-Associated Pruritus

Started: 6/17/2022

NCT06422117 Phase 3 NOT YET RECRUITING

Efficacy and Safety of HSK16149 Capsule in the Treatment of Moderate and Severe Central Neuropathic Pain in China

Started: 5/30/2024

NCT05390905 Phase 3 COMPLETED

A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment

Started: 6/8/2022

NCT05140863 Phase 3 COMPLETED

To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Postherpetic Neuralgia

Started: 11/1/2021

NCT04738357 Phase 3 COMPLETED

A Clinical Study to Evaluate Efficacy and Safety of HSK21542 for Postoperative Analgesia of Subjects Undergoing Elective Laparoscopic Surgery Under General Anesthesia

Started: 3/24/2021

NCT04958746 Phase 3 COMPLETED

Phase III Clinical Trial Evaluating the Efficacy and Safety of Ciprofol Injection for the Induction of Sedation/Anesthesia in Subjects Undergoing Gynecological Outpatient Surgeries

Started: 7/26/2021

NCT04511728 Phase 3 COMPLETED

A Study to Evaluate the Efficacy and Safety of HSK3486 in the Induction of General Anesthesia

Started: 11/24/2020

NCT04620031 Phase 3 COMPLETED

A Study Evaluating Sedation of Intravenous Administration of HSK3486 Injectable Emulsion in ICU Patients Undergoing Mechanical Ventilation

Started: 12/8/2020

NCT05319275 Phase 3 COMPLETED

Study of Acetyllevocarnitine Hydrochloride Tablets in Chinese Patients With Paresthesias Caused by DPN

Started: 7/23/2020

NCT07335055 Phase 2 RECRUITING

A Study for HSK47388 in Participants With Ulcerative Colitis

Started: 2/3/2026

NCT07363460 Phase 2 RECRUITING

Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN

Started: 11/18/2025

NCT06745622 Phase 2 RECRUITING

Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria

Started: 1/3/2025

NCT06670352 Phase 2 RECRUITING

Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients with Primary IgAN

Started: 10/12/2024

NCT06490484 Phase 2 RECRUITING

Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to Pregabalin

Started: 4/19/2024

NCT07533786 Phase 2 NOT YET RECRUITING

A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery

Started: 4/20/2026

NCT06764862 Phase 2 COMPLETED

Evaluating the Efficacy and Safety of of HSK44459 in People With Idiopathic Pulmonary Fibrosis

Started: 1/17/2025

NCT07140328 Phase 2 ACTIVE NOT RECRUITING

Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)

Started: 4/24/2025

NCT07108699 Phase 2 ACTIVE NOT RECRUITING

Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)

Started: 8/13/2025

NCT07442877 Phase 2 COMPLETED

A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic Surgery

Started: 9/13/2024

NCT07425210 Phase 2 NOT YET RECRUITING

Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPD

Started: 3/1/2026

NCT06168383 Phase 2 COMPLETED

To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) .

Started: 1/5/2024

NCT07331402 Phase 2 ACTIVE NOT RECRUITING

A Clinical Study Evaluating the Pharmacokinetics and Pharmacodynamics of HSK39004 Inhalation Suspension in COPD Patients

Started: 7/28/2025

NCT07158268 Phase 2 NOT YET RECRUITING

A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis

Started: 9/1/2025

NCT07150988 Phase 2 NOT YET RECRUITING

A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis

Started: 9/26/2025

NCT07070739 Phase 2 NOT YET RECRUITING

A Long-term Study of HSK44459 Tablets in Participants With Bechet's Disease

Started: 7/1/2025

NCT06561841 Phase 2 COMPLETED

A Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria(PNH)

Started: 7/17/2024

NCT07019090 Phase 2 NOT YET RECRUITING

Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF)

Started: 6/27/2025

NCT06902428 Phase 2 NOT YET RECRUITING

Evaluating the Efficacy and Safety of of HSK44459 in Patients With Behçet's Disease

Started: 3/24/2025

NCT06820749 Phase 2 ENROLLING BY INVITATION

A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Airway Mucus Hypersecretion

Started: 12/10/2024

NCT06637254 Phase 2 ENROLLING BY INVITATION

A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma

Started: 10/22/2024

NCT04727580 Phase 2 COMPLETED

HSK7653 in Chinese Patients with Impaired Glucose Tolerance

Started: 3/29/2021

NCT06703268 Phase 2 COMPLETED

A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes Patients

Started: 1/15/2024

NCT06619210 Phase 2 COMPLETED

A Trial to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients with COPD

Started: 1/12/2022

NCT05601778 Phase 2 COMPLETED

A Study of HSK31858 in Participants with Non-Cystic Fibrosis Bronchiectasis

Started: 12/6/2022

NCT04424251 Phase 2 COMPLETED

Efficacy and Safety of HSK21542 in Inducing Postoperative Analgesia in Undergoing Elective Laparoscopic Surgery

Started: 7/2/2020

NCT05795517 Phase 2 COMPLETED

Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease(NAFLD)

Started: 4/26/2023

NCT05763550 Phase 2 COMPLETED

To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Herpetic Neuralgia

Started: 2/27/2023

NCT06059326 Phase 2 COMPLETED

Multiple-dose Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of HSK7653 in T2DM

Started: 1/22/2019

NCT06007066 Phase 2 COMPLETED

HSK16149 for Perioperative Analgesia in Orthopedic Surgery

Started: 3/8/2023

NCT04470128 Phase 2 COMPLETED

A Study Evaluating the Efficacy and Safety of HSK21542 Injection for Analgesia in Subjects Undergoing Colonoscopy

Started: 8/19/2020

NCT04999787 Phase 2 COMPLETED

A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of HSK21542 Injection in Liver Disease Subjects With Pruritus

Started: 9/16/2021

NCT04470154 Phase 2 COMPLETED

A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of HSK21542 Injection in Subjects Undergoing Hemodialysis

Started: 8/10/2020

NCT04669821 Phase 2 COMPLETED

A Clinical Study Evaluating Sedation of Intravenous Administration of HSK3486 in ICU Patients Undergoing Long-Term Mechanical Ventilation

Started: 3/9/2021

NCT07551739 Phase 2 NOT YET RECRUITING

A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Orthopedic Surgery

Started: 4/1/2026

NCT07521345 Phase 1 RECRUITING

A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablets in Healthy Subjects.

Started: 3/20/2026

NCT07283796 Phase 1 RECRUITING

A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma

Started: 8/28/2025

NCT07158710 Phase 1 RECRUITING

Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 Mutation

Started: 8/15/2025

NCT07152288 Phase 1 RECRUITING

Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HSK39297 in Subjects With Hepatic Impairment

Started: 5/29/2025

NCT07007910 Phase 1 RECRUITING

Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate Cancer

Started: 12/18/2024

NCT06968572 Phase 1 RECRUITING

Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion

Started: 4/11/2025

NCT06536400 Phase 1 RECRUITING

Phase I Study of HSK42360 in Solid Tumors With BRAF V600 Mutation

Started: 6/25/2024

NCT06050980 Phase 1 RECRUITING

Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation

Started: 3/27/2023

NCT07561554 Phase 1 RECRUITING

Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation

Started: 3/6/2026

NCT07519278 Phase 1 COMPLETED

Bioequivalence Study of Pramipexole Dihydrochloride Extended-release Tablets in Healthy Chinese Subjects

Started: 3/16/2017

NCT07134478 Phase 1 ACTIVE NOT RECRUITING

Clinical Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of HSK31858 in Healthy Subjects

Started: 10/28/2024

NCT07134465 Phase 1 ENROLLING BY INVITATION

Clinical Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HSK31858 in Healthy Subjects

Started: 8/11/2025

NCT07192692 Phase 1 COMPLETED

Food Effect Study of HSK47388 in Healthy Subjects

Started: 8/8/2025

NCT07057609 Phase 1 COMPLETED

Bioequivalence Study of Propofol Medium and Long Chain Fat Emulsion Injection in Healthy Chinese Subjects

Started: 10/16/2018

NCT07054255 Phase 1 COMPLETED

Bioequivalence Study of Ranolazine Extended-release Tablets in Healthy Chinese Subjects

Started: 9/6/2020

NCT06971198 Phase 1 COMPLETED

Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HSK39004 Dry Powder Inhalation

Started: 2/10/2025

NCT06926218 Phase 1 NOT YET RECRUITING

This Study is to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of HSK47388 in Healthy Volunteers

Started: 5/1/2025

NCT06905847 Phase 1 COMPLETED

Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Primary Efficacy of HSK39004 Suspension for Inhalation

Started: 9/2/2024

NCT06858657 Phase 1 COMPLETED

A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK44459 in Healthy Subjects

Started: 8/17/2024

NCT06852092 Phase 1 COMPLETED

Study on Mass Balance of [14C]HSK39297 in Healthy Chinese Adult Male Subjects

Started: 9/9/2024

NCT06350279 Phase 1 COMPLETED

A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK39297 in Healthy Subjects

Started: 12/25/2023

NCT06238388 Phase 1 COMPLETED

Metabolism and Excretory of HSK21542 in Maintenance Hemodialysis Patients

Started: 10/10/2023

NCT05531097 Phase 1 COMPLETED

Ascending Single-Dose and Multiple-Dose Study to Evaluate HSK31679 in Healthy Subjects and Subjects With Elevated LDL-C

Started: 2/22/2022

NCT05881811 Phase 1 COMPLETED

The Drug-drug Interaction of HSK16149 Capsule With Probenecid Tablets or Cimetidine Tablets in Healthy Subjects

Started: 3/20/2023

NCT06084156 Phase 1 COMPLETED

A Study to Evaluate the DDI of HSK7653 With Metformin

Started: 8/10/2019

NCT06003088 Phase 1 COMPLETED

Relative Bioavailability and Pharmacodynamics of HSK7653 in Healthy Volunteers

Started: 6/15/2022

NCT05983289 Phase 1 COMPLETED

Single Escalating Dose Study Of HSK7653 In Healthy Subjects

Started: 5/8/2018

NCT05916573 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics of HSK16149 in Subjects With Renal Impairment

Started: 12/12/2022

NCT05835934 Phase 1 COMPLETED

Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK21542 in Healthy Adult Male Volunteers.

Started: 6/15/2021

NCT05742126 Phase 1 COMPLETED

A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Dosed of HSK36273 in Healthy Volunteers

Started: 4/11/2022

NCT04687813 Phase 1 COMPLETED

Safety, Tolerability and Pharmacokinetics of FTP-198 Tablet in Healthy Chinese Volunteers

Started: 12/23/2020

NCT05497297 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment

Started: 8/4/2022

NCT05663593 Phase 1 COMPLETED

Safety, Tolerability,PK/PD, Food Effect of Single and Multiple Ascending Doses of HSK31858 in Healthy Volunteers

Started: 2/23/2022

NCT05023525 Phase 1 COMPLETED

A Study of Safety, Tolerability, and Pharmacokinetics of Single Ascending Dosed of HSK31858 in Healthy Volunteers

Started: 10/28/2021

NCT05181007 Phase 1 COMPLETED

Drug-drug Interaction Between Ciprofol and Mefanamic Acid or Valproate

Started: 12/17/2021

NCT04294056 Phase 1 COMPLETED

A Study to Evaluate the Differences in Pharmadynamics, Pharmacokinetics, and Safety Between Ciprofol and Propofol

Started: 5/26/2020

NCT07558967 Phase 1 COMPLETED

Bioequivalence Study of Tenofovir Disoproxil Fumarate Tablets in Healthy Chinese Subjects

Started: 6/20/2017

NCT07551713 Phase 1 COMPLETED

Bioequivalence Study of Lidocaine and Prilocaine Cream in Healthy Chinese Subjects

Started: 6/11/2020

NCT06740201 Phase 4 RECRUITING

A Study to Evaluate the Accuracy of aTCI Model of Cipepofol in Patients With General Anesthesia During Elective Surgery

Started: 1/6/2025

Drug Candidates

HSK55718 dose level1 HSK55718 dose level2 HSK55718 dose level 3 Placebo control morphine Test formulation(pramipexole dihydrochloride extended-release tablets) Reference formulation(MIRAPEX ER®) HSK44459 dose 1 HSK44459 dose 2 HSK44459 dose 3
Activity Status: Active
Last Trial Started: 5/1/2026
Last Trial Ended: 3/4/2026
Trials (12 months): 24
Completed Trials: 56
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.